Beverly Roy on Making Clinical Judgment More Reliable in the Age of Medical AI
Healthcare AI is often framed through a narrow lens of replacement. The dominant narrative may suggest a future where machines take over clinical decision-making, reducing the role of physicians. Beverly Roy, Founder of Elionyx Health, sees that premise as fundamentally flawed. In her view, the real opportunity lies in strengthening clinical judgment and making it more reliable, consistent and scalable.
Healthcare systems today face mounting strain, driven by increasingly complex patient needs, rising clinical and administrative workloads and persistent gaps in care coordination across primary care and specialist services.
Roy believes these challenges are deeply interconnected and solvable. She points to misdiagnosis and misreferral as one of the most overlooked sources of cost and inefficiency in healthcare. “Misdiagnosis and misreferral are some of the most expensive costs in healthcare that can be eliminated. It is low-hanging fruit that we can make disappear with accurate, timely decision-making,” she says.
This insight underpins RealDiag, a diagnostic referral support platform developed under Elionyx Health. According to the company, RealDiag is designed to function within existing electronic medical record systems, analyzing patient data in real time and providing diagnostic guidance. The goal is to equip physicians with structured, evidence-based insights that improve both accuracy and speed.
Roy emphasizes that the platform does not remove decision-making from physicians. It consolidates complex information into a format that enables more informed judgment. “When you look at a patient’s chart, you cannot possibly go through all of the information and come to a conclusion very quickly, especially in complicated cases. AI can help bring that information together so the physician can act with clarity,” she explains.
According to her, the foundation of this approach lies in credible clinical sourcing. Roy highlights how leading clinical frameworks are developed through collaboration among physicians across disciplines, creating standardized pathways for diagnosis and treatment. These same principles, she adds, inform the system’s architecture.
Roy is clear about the role of human oversight in AI-driven healthcare. “This is the physician’s decision. The system is there to bring together information so an informed decision can be made. We should never, under any circumstances, remove the rails,” she says. She recounts a personal experience where relying on AI without verification led to a missed component in a grant proposal, reinforcing the need for continuous human review.
According to her, this philosophy extends to how RealDiag integrates into healthcare environments. “We do not take any data out. It lives within the EMR. It simply analyzes what is already there and provides insight based on that information. This design prioritizes data security while enabling seamless adoption,” Roy explains.
Beyond diagnostics, Roy believes RealDiag addresses a persistent challenge in clinical practice: variability in terminology and training across regions. She notes that the platform bridges differences in how conditions are described globally. This, she adds, allows physicians trained in different healthcare systems to align around a shared clinical language, helping improve communication and consistency in care.
Roy also highlights the system’s adaptability. Traditional healthcare infrastructure is often slow to evolve due to systemic complexity, regulatory fragmentation, and misalignment between strategy and implementation, while AI-driven systems offer the potential to enhance efficiency and enable more responsive, data-driven decision-making. “Healthcare systems are difficult to change, even when everyone agrees a change is needed. With AI, we can update quickly and continuously refine the system,” she says.
According to her, the origin of RealDiag reflects a longstanding gap in care coordination. Early in her career, Roy witnessed firsthand the impact of misdirected referrals. She says families often traveled long distances for specialist consultations that were unnecessary, while critical cases competed for limited access. For her, that experience revealed a structural inefficiency that manual intervention could not solve at scale.
“Parents would take time off work and pull their children out of school to see a specialist they did not need. It showed me that the system lacked a way to guide referrals accurately. That problem still exists today,” she recalls. She emphasizes that RealDiag represents an effort to address that gap through intelligent, scalable support.
As healthcare systems confront growing demand with constrained resources, Roy believes that tools that enhance physician capability become essential. She emphasizes that empowering clinicians to work more effectively will define the next phase of healthcare innovation.
“It is only going to get more challenging. We have fewer physicians entering the field and a growing population. They need support. Technology exists to provide that support, and we should use it responsibly,” she says.
For Roy, the future of healthcare AI depends on trust. That trust could be earned through systems that are transparent, clinically grounded, and designed to heighten human expertise. She believes solutions that prioritize reliability over automation will shape how AI is integrated into everyday care.
“The goal is to make clinical judgment more consistent and dependable. AI should help physicians see more, understand more, and act with greater confidence,” Roy says. “We will always need the rails. We will always need professionals leading the medical decisions.”
